Amanta Healthcare IPO
mainboardListed
GMP
₹9
mainboardListed
Amanta Healthcare IPO
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹9
(+7.14%) Est. Gain
Investment Timeline
✓
IPO Open
1 Sept 2025
✓
IPO Close
3 Sept 2025
✓
Allotment
4 Sept 2025
✓
Listing
9 Sept 2025
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
NEUTRAL
51.5/100
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
⚡ URGENT: Apply on DAY 1 MORNING - Extremely high demand! Allotment probability very low
Key Factor Analysis
🚀
Demand
🚀 Exceptional subscription! Massive oversubscription across all categories
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
⚠️ Limited listing gains expected (0-5%)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹120.00-126.00
📦Lot Size
119 shares
💰Issue Size
₹126.00 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Amanta Healthcare IPO?
As of today, the Grey Market Premium (GMP) for Amanta Healthcare IPO is ₹9, which is approximately (+7.14%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Amanta Healthcare IPO?
Our AI algorithm currently rates this IPO as "NEUTRAL" with a score of 51.5/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Amanta Healthcare IPO be announced?
The allotment status for Amanta Healthcare IPO is expected to be finalized on 4 Sept 2025. Investors can check their status on the registrar's website.
What is the listing date for Amanta Healthcare IPO?
Shares of Amanta Healthcare IPO are proposed to be listed on stock exchanges on 9 Sept 2025.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.